Zobrazeno 1 - 7
of 7
pro vyhledávání: '"G V, Varlan"'
Autor:
Yu. V. Vasyuk, V. V. Nesvetov, E. L. Shkolnik, L. D. Shkolnik, G. V. Varlan, G. E. Gendlin, E. I. Emelina
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 13, Iss 2, Pp 184-190 (2017)
Aim. To study the efficacy of ivabradine in the prevention of cardiotoxic effects due to chemotherapeutic drugs in patients with breast cancer. Material and methods. The open randomized uncontrolled study included 55 patients with breast cancer who h
Externí odkaz:
https://doaj.org/article/ac349014a6fe4c64b4fc8ed37404bd49
Publikováno v:
КардиоСоматика, Vol 4, Iss 4, Pp 20-24 (2013)
Recent years have seen significant progress in the treatment of many oncologicaldiseases associated with the development of new chemotherapeutic agents. Typically, they are used in combination with classical chemotherapy regimens that in-clude doxoru
Externí odkaz:
https://doaj.org/article/3e918cdb1e3f4e50ad05342ec304c0ee
Autor:
D Shevola, N V Dmitrieva, I N Petukhova, G V Varlan, N A Averina, Z V Volkova, N N Petrukhina, A M Korotkov
Publikováno v:
Современная онкология, Vol 5, Iss 3, Pp 125-127 (2003)
Инфекции являются одной из наиболее частых причин заболеваемости и смертности онкологических больных, особенно получающих паллиативн
Externí odkaz:
https://doaj.org/article/5927141c8c924466aee3cd8462677773
Publikováno v:
Современная онкология, Vol 3, Iss 3, Pp 98-100 (2001)
Среди всех нозокомиальных (госпитальных) инфекций 71 % составляют инфекции, развившиеся у больных после той или иной операции. Среди этих
Externí odkaz:
https://doaj.org/article/ddf12af2bbff47048a47f12ec33bc26c
Autor:
L. D. Shkolnik, E. I. Emelina, Yu. V. Vasyuk, V. V. Nesvetov, E. L. Shkolnik, G. V. Varlan, G. E. Gendlin
Publikováno v:
Racionalʹnaâ Farmakoterapiâ v Kardiologii, Vol 13, Iss 2, Pp 184-190 (2017)
Aim. To study the efficacy of ivabradine in the prevention of cardiotoxic effects due to chemotherapeutic drugs in patients with breast cancer. Material and methods. The open randomized uncontrolled study included 55 patients with breast cancer who h
Publikováno v:
Kardiologiia. 56(12)
Anthracyclines including doxorubicin, epirubicin, daunorubicin, aclarubicin are extensively used as chemotherapeutic agents for treatment of hematological and other malignancies. In cancer therapy anthracyclines are often used in combinations with ot
Publikováno v:
Vestnik rentgenologii i radiologii. (5)